{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013892","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.753981+00:00","generated_at":"2026-05-17T06:22:39.803618+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"bioAffinity Technologies announces 1-for-30 reverse stock split effective Sept 19, 2025","bullets":["1-for-30 reverse stock split effective at open of trading on Nasdaq on September 19, 2025.","Post-split outstanding shares approximately 1,338,029; fractional shares paid in cash.","Reverse split intended to bring Company into compliance with Nasdaq minimum bid price requirement.","Proportionate adjustments to exercise prices and shares underlying stock options and warrants.","CUSIP for common stock changes to 09076W307; trading symbol BIAF unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013892","json":"https://secwatch.observer/filing/0001493152-25-013892.json","markdown":"https://secwatch.observer/filing/0001493152-25-013892.md","text":"https://secwatch.observer/filing/0001493152-25-013892.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/0001493152-25-013892-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225013892/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:22:39.803618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}